Omecamtiv mecarbilcardiac
To Order Now: info@anbioq.org
 Omecamtiv mecarbil |
|||
| A8349-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 199 |
|
Description: Omecamtiv mecarbil (CK-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin S1 domain but not other muscle myosins. In clinical trials, omecamtiv mecarbil has been considered as a promising therapeutic approach to treat systolic heart failure1. |
|||
Omecamtiv mecarbil |
|||
| A8349-50 | ApexBio | 50 mg | EUR 837 |
|
Description: Omecamtiv mecarbil (CK-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin S1 domain but not other muscle myosins. In clinical trials, omecamtiv mecarbil has been considered as a promising therapeutic approach to treat systolic heart failure1. |
|||
Omecamtiv mecarbil |
|||
| A8349-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Omecamtiv mecarbil (CK-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin S1 domain but not other muscle myosins. In clinical trials, omecamtiv mecarbil has been considered as a promising therapeutic approach to treat systolic heart failure1. |
|||
) Omecamtiv mecarbil (CK-1827452) |
|||
| E1KS2623 | EnoGene | 5mg | EUR 874 |